Viropharma, Inc. (VPHM) Tops Q2 EPS by 2c
Tweet
Share
E-mailGet Alerts VPHM Hot Sheet
Join SI Premium – FREE
Viropharma, Inc. (NASDAQ: VPHM) reported Q2 non-GAAP EPS of $0.40, $0.02 better than the analyst estimate of $0.38. Revenue for the quarter came in at $128.8 million versus the consensus estimate of $130.5 million.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Andersen Group Inc. (ANDG) Reports Q2 Loss of $0.09; offers guidance
- BioCardia (BCDA) Tops Q2 EPS by 5c
- Identiv (INVE) Misses Q2 EPS by 5c, Misses on Revenue
Create E-mail Alert Related Categories
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
